about
Phenylephrine eye drops in pediatric patients undergoing ophthalmic surgery: incidence, presentation, and management of complications during general anesthesia.Cavernous venous malformation (cavernous hemangioma) of the orbit: Current concepts and a review of the literature.Surgical treatment of total bilateral ankyloblepharon in a child: unusual case report.Intraorbital injection of rituximab versus high dose of systemic glucocorticoids in the treatment of thyroid-associated orbitopathy.A Modified One-Stage Early Correction of Blepharophimosis Syndrome Using Tutopatch Slings.Prevalence of neurological involvement and malformative/systemic syndromes in A- and V-pattern strabismus.Secondary orbital and intraocular lymphoma treated with immunochemotherapy.Surgical treatment of obstruction of the nasolacrimal ducts in patients with anatomical endonasal variants.Intraorbital injection of Rituximab in idiopathic orbital inflammatory syndrome: case reports.Ocular manifestations in Wolf-Hirschhorn syndrome.Atypical presentation of a case of solitary fibrous tumor of the orbit.Restrictive Limitation of Sursumduction Caused by an Anomalous Muscular StructureFocal dermal hypoplasia (goltz-gorlin syndrome): A new case with a novel variant in thePORCNgene (c.1250T>C:p.F417S) and unusual spinal anomalyChronic Lymphocytic Leukemia With Eyelid Involvement Responding to AlemtuzumabFour diopters prism test recording in small angle esotropia: a quantitative study using a magnetic search coilIntralesional administration of rituximab for treatment of CD20 positive orbital lymphoma: safety and efficacy evaluationEvaluation of intraorbital injection of rituximab for treatment of primary ocular adnexal lymphoma: a pilot studyAmniotic membrane transplantation associated with a corneal patch in a paediatric corneal perforationRelation of the eighth edition of the American Joint Committee on Cancer staging system with histological risk classification for primary eyelid basal cell carcinoma
P50
Q38172639-1984E581-F3C6-46AE-8AE9-B40306EF46AFQ39107944-4A76BBB0-4D41-435B-B61F-320D3E2C1BB7Q43880103-D347E042-AA54-4CC3-A4F9-52FD375D4FEBQ44766839-231694A8-C118-4E56-BAA5-205DADD6F3C4Q48794089-F2FBE38E-73F8-4340-9346-25F292672836Q49082594-F27B240A-85AC-4324-89EB-56C37DFA0868Q50478138-14FEC049-FF52-4625-AA6E-9459C75E365FQ51010698-DFA15896-162E-4450-A39A-FEE676A39369Q51321732-42A9A368-EA76-4994-B846-AAA0E4ADE0F5Q51867358-1D894293-636A-46C9-A787-CD55667C6819Q53328603-A4CCEB1C-F692-49E1-B208-9D8E6946D6EBQ58000761-5DD885CF-8CE8-4172-96CF-B08B9FCCA5E0Q62027148-C18CB7A0-84EA-457E-AD30-E14324D2F673Q64026773-8CEC58BF-2BC5-4DBB-8D9E-5A098F52408BQ73330605-EBDB79DD-B020-4097-AEE4-358806369683Q83444461-6CB3A2FE-3D8D-4ADE-87E8-2D8A522F80C3Q84081956-E247850D-97A1-420C-9A01-1BCCFA622599Q84591714-CCEB63DB-6F38-4CBF-9814-9DC831D7FA43Q94955990-D7A957DD-1F30-4071-A576-2EDFF0BB9862
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Gustavo Savino
@ast
Gustavo Savino
@en
Gustavo Savino
@es
Gustavo Savino
@nl
type
label
Gustavo Savino
@ast
Gustavo Savino
@en
Gustavo Savino
@es
Gustavo Savino
@nl
prefLabel
Gustavo Savino
@ast
Gustavo Savino
@en
Gustavo Savino
@es
Gustavo Savino
@nl
P106
P1153
7004140727
P21
P31
P496
0000-0002-9993-5986